Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 1
1991 1
1996 1
1997 2
1999 1
2002 2
2003 1
2007 3
2008 2
2009 1
2010 3
2011 1
2012 2
2013 6
2014 11
2015 10
2016 6
2017 4
2018 4
2019 2
2020 2
2021 4
2022 7
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE; RIM Study Group. Oddis CV, et al. Among authors: ascherman dp. Arthritis Rheum. 2013 Feb;65(2):314-24. doi: 10.1002/art.37754. Arthritis Rheum. 2013. PMID: 23124935 Free PMC article. Clinical Trial.
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-O'Callaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. Oldroyd AGS, et al. Nat Rev Rheumatol. 2023 Dec;19(12):805-817. doi: 10.1038/s41584-023-01045-w. Epub 2023 Nov 9. Nat Rev Rheumatol. 2023. PMID: 37945774 Review.
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.
Amato AA, Hanna MG, Machado PM, Badrising UA, Chinoy H, Benveniste O, Karanam AK, Wu M, Tankó LB, Schubert-Tennigkeit AA, Papanicolaou DA, Lloyd TE, Needham M, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Aoki M, Katsuno M, Morihata H, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Zhang Auberson L; RESILIENT Study Extension Group. Amato AA, et al. Among authors: ascherman dp. Neurology. 2021 Mar 23;96(12):e1595-e1607. doi: 10.1212/WNL.0000000000011626. Epub 2021 Feb 17. Neurology. 2021. PMID: 33597289 Free PMC article. Clinical Trial.
Pulmonary manifestations of polymyositis/dermatomyositis.
Hallowell RW, Ascherman DP, Danoff SK. Hallowell RW, et al. Among authors: ascherman dp. Semin Respir Crit Care Med. 2014 Apr;35(2):239-48. doi: 10.1055/s-0034-1371528. Epub 2014 Mar 25. Semin Respir Crit Care Med. 2014. PMID: 24668538 Review.
Risk Factors and Cancer Screening in Myositis.
Moghadam-Kia S, Oddis CV, Ascherman DP, Aggarwal R. Moghadam-Kia S, et al. Among authors: ascherman dp. Rheum Dis Clin North Am. 2020 Aug;46(3):565-576. doi: 10.1016/j.rdc.2020.05.006. Epub 2020 Jun 7. Rheum Dis Clin North Am. 2020. PMID: 32631604 Review.
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
Saygin D, Kim H, Douglas C, Erman B, Wilkerson J, McGrath JA, Oddis CV, Lundberg IE, Amato AA, García-De La Torre I, Chinoy H, Fiorentino D, Chung L, Song YW, Miller FW, Ruperto N, Vencovsky J, Aggarwal R, Rider LG; International Myositis Assessment and Clinical Studies Group (IMACS). Saygin D, et al. Rheumatology (Oxford). 2023 Nov 2;62(11):3672-3679. doi: 10.1093/rheumatology/kead110. Rheumatology (Oxford). 2023. PMID: 36929923 Free PMC article.
Pulmonary complications of inflammatory myopathy.
Miller SA, Glassberg MK, Ascherman DP. Miller SA, et al. Among authors: ascherman dp. Rheum Dis Clin North Am. 2015 May;41(2):249-62. doi: 10.1016/j.rdc.2014.12.006. Epub 2015 Feb 27. Rheum Dis Clin North Am. 2015. PMID: 25836641 Review.
Animal models of inflammatory myopathy.
Ascherman DP. Ascherman DP. Curr Rheumatol Rep. 2012 Jun;14(3):257-63. doi: 10.1007/s11926-012-0245-7. Curr Rheumatol Rep. 2012. PMID: 22350609 Review.
87 results